Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis by Miura, Fumihiko et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tokyo Guidelines 2018: initial management of acute biliary
infection and flowchart for acute cholangitis
Citation for published version:
Miura, F, Okamoto, K, Takada, T, Strasberg, SM, Asbun, HJ, Pitt, HA, Gomi, H, Solomkin, JS, Schlossberg,
D, Han, H, Kim, M, Hwang, T, Chen, M, Huang, WS, Kiriyama, S, Itoi, T, Garden, OJ, Liau, K, Horiguchi, A,
Liu, K, Su, C, Gouma, DJ, Belli, G, Dervenis, C, Jagannath, P, Chan, ACW, Lau, WY, Endo, I, Suzuki, K,
Yoon, Y, De Santibañes, E, Giménez, ME, Jonas, E, Singh, H, Honda, G, Asai, K, Mori, Y, Wada, K,
Higuchi, R, Watanabe, M, Rikiyama, T, Sata, N, Kano, N, Umezawa, A, Mukai, S, Tokumura, H, Hata, J,
Kozaka, K, Iwashita, Y, Hibi, T, Yokoe, M, Kimura, T, Kitano, S, Inomata, M, Hirata, K, Sumiyama, Y, Inui, K
& Yamamoto, M 2018, 'Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart
for acute cholangitis' Journal of Hepato-Biliary-Pancreatic Sciences, vol. 25, no. 1. DOI: 10.1002/jhbp.509
Digital Object Identifier (DOI):
10.1002/jhbp.509
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Journal of Hepato-Biliary-Pancreatic Sciences
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 09. May. 2019
A
cc
ep
te
d 
A
rt
ic
le
This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1002/jhbp.509 
This article is protected by copyright. All rights reserved. 
Guideline 
Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for 
acute cholangitis 
Fumihiko Miura, Kohji Okamoto, Tadahiro Takada, Steven M. Strasberg, Horacio J. 
Asbun, Henry A. Pitt, Harumi Gomi, Joseph S. Solomkin, David Schlossberg, Ho-Seong 
Han, Myung-Hwan Kim, Tsann-Long Hwang, Miin-Fu Chen, Wayne Shih-Wei Huang, 
Seiki Kiriyama, Takao Itoi, O. James Garden, Kui-Hin Liau, Akihiko Horiguchi, 
Keng-Hao Liu, Cheng-Hsi Su, Dirk Joan Gouma, Giulio Belli, Christos Dervenis, Palepu 
Jagannath, Angus C.W. Chan, Wan Yee Lau, Itaru Endo, Kenji Suzuki, Yoo-Seok Yoon, 
Eduardo de Santibañes, Mariano Eduardo Giménez, Eduard Jonas, Harjit Singh, Goro 
Honda, Koji Asai, Yasuhisa Mori, Keita Wada, Ryota Higuchi, Manabu Watanabe, 
Toshiki Rikiyama, Naohiro Sata, Nobuyasu Kano, Akiko Umezawa, Shuntaro Mukai, 
Hiromi Tokumura, Jiro Hata, Kazuto Kozaka, Yukio Iwashita, Taizo Hibi, Masamichi 
Yokoe, Taizo Kimura, Seigo Kitano, Masafumi Inomata, Koichi Hirata, Yoshinobu 
Sumiyama, Kazuo Inui, Masakazu Yamamoto 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
The author’s affiliations are listed in the Appendix. 
 
Corresponding to: Tadahiro Takada, MD, PhD, Department of Surgery, Teikyo 
University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan. 
E-mail: t-takada@jshbps.jp 
 
Abstract 
The initial management of patients with suspected acute biliary infection starts with 
the measurement of vital signs to assess whether or not the situation is urgent. If the case 
is judged to be urgent, initial medical treatment should be started immediately including 
respiratory/circulatory management if required, without waiting for the definitive 
diagnosis. The patient’s medical history is then taken; an abdominal examination is 
performed; blood tests, urinalysis, and diagnostic imaging are carried out; and a 
diagnosis is made using the diagnostic criteria for cholangitis/cholecystitis. Once the 
diagnosis has been confirmed, initial medical treatment should be started immediately, 
severity should be assessed according to the severity grading criteria for acute 
cholangitis/cholecystitis, and the patient’s general status should be evaluated. 
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 For mild acute cholangitis, in most cases initial treatment including antibiotics is 
sufficient, and most patients do not require biliary drainage. However, biliary drainage 
should be considered if a patient does not respond to initial treatment. 
For moderate acute cholangitis, early endoscopic or percutaneous transhepatic biliary 
drainage is indicated. If the underlying etiology requires treatment, this should be 
provided after the patient’s general condition has improved; endoscopic sphincterotomy 
(EST) and subsequent choledocholithotomy may be performed together with biliary 
drainage. 
For severe acute cholangitis, appropriate respiratory/circulatory management is 
required. Biliary drainage should be performed as soon as possible after the patient’s 
general condition has been improved by initial treatment and respiratory/circulatory 
management. 
 
Key words: initial treatment, acute cholangitis, acute cholecystitis, biliary drainage, 
guidelines 
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Introduction 
Acute biliary infection, particularly acute cholangitis, may cause a rapid deterioration 
in condition due to sepsis, and prompt and appropriate treatment is therefore required. 
There were no clear management guidelines available until 2007, when we first proposed 
a flowchart illustrating guidelines for the management of acute cholangitis and acute 
cholecystitis according to the severity grades in the Tokyo Guidelines 2007 (TG07) [1]. 
The TG07 flowchart was established on the basis of the consensus reached in the 
International Consensus Meeting held in Tokyo in April 2006. The TG07 flowchart has 
been cited in numerous publications and has had a major impact on everyday clinical 
practice and clinical research [2]. The Tokyo Guidelines were revised in 2013 as the Tokyo 
Guidelines 2013 (TG13) [2], and the Tokyo Guidelines 2018 (TG18) is the third revised 
version. 
 
In TG18, part of the flowchart for the management of moderate acute cholangitis has 
been somewhat revised from TG13. The flowchart for the management of acute 
cholecystitis, however, has undergone major revisions compared with TG13. In TG07 and 
TG13, the flowcharts for the management of acute cholangitis and acute cholecystitis 
were published together in a single paper, but for the TG18 the initial response to acute 
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biliary infection and the flowchart for management of acute cholangitis are dealt with in 
this paper, while the flowchart for the management of acute cholecystitis is reported in a 
separate publication [3]. 
 
Flowchart for the initial response to acute biliary infection (Figure 1) 
The initial management of patients with suspected acute biliary infection starts with 
the measurement of vital signs to assess whether or not the situation is urgent. If the case 
is judged to be urgent, initial medical treatment should be started immediately including 
respiratory/circulatory management if required, without waiting for the definitive 
diagnosis. 
A detailed examination (consultation and physical examination) is then performed, 
after which blood tests and diagnostic imaging are performed; on the basis of the results, 
a definitive diagnosis is made following the diagnostic criteria for acute cholangitis and 
cholecystitis (clinical practice guidelines, CPG)[4–9]. 
Once the diagnosis has been confirmed, initial medical treatment should be started 
immediately, the severity should be assessed according to the severity grading criteria for 
acute cholangitis/cholecystitis, and the patient’s general status should be evaluated. The 
Charlson co-morbidity index (CCI) (case series, CS) [10] and the American Society of 
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Anesthesiologists (ASA) Physical Status (PS) classification [11] are useful for the 
evaluation of general status. After the severity assessment, a treatment strategy should 
be decided on the basis of the flowchart for the management of acute cholangitis or acute 
cholecystitis, and treatment should immediately be provided. 
General status and signs when acute biliary infection is suspected 
Symptoms indicative of suspected acute biliary infection are fever, chills, abdominal 
pain, jaundice, nausea, vomiting, and disturbance of consciousness. If even one of these 
symptoms is present, acute biliary infection is suspected and it is necessary to proceed to 
diagnosis (CPG)[12]. 
Management of patients with suspected acute biliary infection  
Vital signs include blood pressure, heart rate, respiration rate, temperature, urine 
volume, oxygen saturation (SpO2), and consciousness level. The consultation should 
include a detailed medical history of the timing of the appearance of symptoms and their 
nature. Patients should be asked about their previous medical history and regular 
medications. In the physical examination, the evaluation and measurement of the 
patient’s state of consciousness goes without saying, and the presence or absence of 
yellowing of the palpebral conjunctiva, the location and severity of tenderness, and 
whether or not there are any symptoms of peritoneal irritation must always be confirmed. 
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The presence or absence of Murphy’s sign (compression of the right upper quadrant 
causes the patient to catch their breath due to pain when taking a deep breath), which is 
specific to acute cholecystitis, must always be confirmed.  
Tests required for the diagnosis of acute biliary infection 
Blood tests including white blood cell count, platelet count, C-reactive protein (CRP), 
albumin, alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), bilirubin, blood urea nitrogen 
(BUN), creatinine, prothrombin time (PT), and PT-international normalized ratio (INR) 
are carried out for the purpose of diagnosis and severity grading, and blood gas analysis 
should also be performed (CPG) [12]. If a high fever is present, blood culture should 
preferably be performed at this point. 
In terms of diagnostic imaging, abdominal ultrasound and computed tomography (CT) 
are useful for the diagnosis of acute biliary infection, and at least one of these should be 
performed. Abdominal ultrasound in particular is minimally invasive, widely used, 
simple, and cheap, and should therefore be performed first in patients with suspected 
biliary infection, despite disadvantages including the fact that the results are easily 
affected by the operator’s skill and the patient’s condition (CPG)[6]. 
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Inflammation in acute cholangitis is difficult to assess on diagnostic imaging, but it is 
possible to evaluate dilatation of the bile duct, or bile congestion due to occlusion/stenosis 
of the bile duct or biliary calculus and its cause (CPG)[12]. 
The distinctive signs of acute cholecystitis on diagnostic imaging include enlargement 
of the gallbladder, gallbladder wall thickening, gallbladder calculi, fluid retention around 
the gallbladder, abscess around the gallbladder, and sludge debris in the gallbladder and 
the sonographic Murphy’s sign (pain when the probe presses on the gallbladder) on 
abdominal ultrasound (CPG)[12]. 
Diagnostic criteria for acute biliary infection 
Diagnosis is made in light of the findings required for diagnosis, as described above, 
using the TG13/18 diagnostic criteria for acute cholangitis (Table 1) (CPG) [4–6] and the 
TG13/18 diagnostic criteria for acute cholecystitis (Table 2) (CPG) [8, 9]. 
Initial treatment 
 Once a definitive diagnosis of acute cholangitis or acute cholecystitis has been reached, 
initial treatment including the infusion of sufficient fluids and antibiotic and analgesic 
administration is started, with careful monitoring of blood pressure, heart rate, and urine 
volume. It goes without saying that if the patient is in a state of shock, initial treatment 
should be started without waiting for a definitive diagnosis. Although there is no 
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high-quality evidence for the merits and demerits of fasting in acute 
cholangitis/cholecystitis, in principle patients should be fasted to enable immediate 
emergency drainage (CPG)[12]. Despite the concern that analgesic administration may 
mask physical signs and cause a mistaken diagnosis, a randomized controlled trial (RCT) 
comparing intravenous morphine hydrochloride and an intravenous placebo for patients 
examined in the emergency room complaining of abdominal pain found no difference 
between them in the rate of diagnosis [13, 14], and analgesics should therefore be 
administered proactively at an early stage. Opioid analgesics such as morphine 
hydrochloride and other similar types of drug (such as non-opioid analgesics and 
pentazocine) cause the sphincter of Oddi to contract, which may elevate biliary pressure, 
and must therefore be administered with caution. 
In the case of serious deterioration, such as the appearance of shock (hypotension), 
disturbance of consciousness, acute dyspnea, acute renal dysfunction, hepatic 
dysfunction, or disseminated intravascular coagulation (DIC) (reduced platelet count), 
emergency biliary drainage should be considered alongside appropriate organ support 
and respiratory/circulatory management (such as artificial ventilation, tracheal 
intubation, and the use of hypertensive agents) (CPG)[12]。   
For guidance on antibiotic administration, see TG18: Antimicrobial therapy for acute 
cholangitis and cholecystitis (CPG) [15]. 
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Severity assessment and general status evaluation 
Alongside initial treatment, severity assessment should be carried out using the 
TG13/18 severity assessment criteria for acute cholangitis (Table 3) (CPG) [4–6] or the 
TG13/18 severity assessment criteria for acute cholecystitis (Table 4) (CPG) [8, 9], and 
the patient’s general status should also be evaluated using the CCI and the ASA-PS 
classification. The severity should be reassessed frequently in accordance with response 
to initial treatment. 
If the patient cannot be treated appropriately, transfer should be considered to an 
advanced center capable of procedures including emergency surgery, interventional 
radiology (IVR), and endoscopy. 
 
CQ 1. How was the TG13 flowchart for acute cholangitis evaluated? (Background 
Question) 
It was shown to require partial revision. (Level D) 
Although no studies have evaluated the flowchart itself, a review was carried out of 
studies that included partial investigations of the treatment guidelines for acute 
cholangitis set out in the flowchart. Two observational studies addressed the timing of 
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biliary drainage by severity grade. A multicenter joint study carried out in Japan and 
Taiwan found that for moderate cholangitis, mortality was significantly lower in 944 
patients who underwent drainage within 24 hours compared with 1,081 patients who 
either underwent drainage after longer than 24 hours or did not undergo drainage (1.7% 
vs. 3.4%, p = 0.0172), but that there was no significant difference for mild or severe 
cholangitis [16]. In the other observational study, which compared 130 patients with mild 
or moderate cholangitis who underwent drainage within 24 hours and 82 who underwent 
drainage after longer than 24 hours, although there was no significant difference in 
mortality which was zero in both groups, the mean duration of hospitalization was 
significantly shorter for patients who underwent drainage within 24 hours (6.8 days vs. 
9.2 days, p  0.01 (CS)[17]. 
The TG13 flowchart proposed that for patients with moderate cholangitis, treatment 
for the underlying etiology should be provided electively after early biliary drainage, and 
that for patients with mild cholangitis due to choledocholiathis, treatment for the 
underlying etiology such as endoscopic sphincterotomy (EST) and choledocholithotomy 
may be performed at the same time as biliary drainage [12]. Three observational studies 
(one of which did not use severity assessment criteria) (CS) [17–19] and one RCT [20] 
showed that single-stage lithotomy was safe and feasible in cases of mild or moderate 
acute cholangitis caused by choledocholithiasis. In the RCT, however, the rate of 
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complications after endoscopic retrograde cholangio-pancreatography (ERCP) was 
significantly higher than that after two-stage lithotomy (6/35 = 17.1% vs. 0/33 = 0%, p = 
0.025) (RCT) [20]; therefore, caution is required. 
Two studies have compared early and elective laparoscopic choledocholithotomy for 
patients with mild or moderate acute cholangitis associated with choledocolithiasis (CS) 
[21, 22]. Early laparoscopic choledocholithotomy was safe and there was no difference in 
the rate of complications, but both studies were carried out in the same institution, 
included few subjects [72 (CS)[21] and 73 (CS)[22], respectively] with a large number of 
exclusions, and did not demonstrate the safety of single-stage laparoscopic 
choledocholithotomy in patients with moderate acute cholangitis. 
At this point, although the value of the TG13 flowchart for acute cholangitis as a whole 
is unclear, its core structure is based on conservative treatment in mild cases and early 
biliary drainage in moderate cases, and as the value of these has been shown in 
large-scale studies to be highly significant, the value of the flowchart has been 
demonstrated to at least some extent. Although the evidence for single-stage treatment 
for the underlying etiology in moderate acute cholangitis (EST followed by 
choledocholithotomy) is still insufficient, the TG18 flowchart for acute cholangitis has 
been amended to show that this is possible in light of the actual situation in clinical 
practice. 
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CQ 2. What treatments other than antibiotics and biliary drainage are effective for severe 
cholangitis? 
(Future research question) 
The administration of recombinant human soluble thrombomodulin (rTM) may be 
considered for severe cholangitis complicated with DIC (Level D). 
Severe cholangitis is often complicated by DIC. Septic DIC is treated with 
anticoagulants such as heparin, antithrombin III, and protease inhibitors. Although 
these anticoagulants have been well studied, including in RCTs, the numbers of 
cholangitis patients in these studies are either unknown or very small, and the value of 
anticoagulants in severe cholangitis is unclear. Two studies have reported the value of 
recombinant human soluble thrombomodulin (rTM) for DIC in patients with acute 
cholangitis (CS)[23, 24]. Suetani et al. divided 66 patients diagnosed with acute 
cholangitis-induced DIC on the basis of the TG13 diagnostic criteria into 33 who were 
treated with rTM and 36 who were not, and found that the DIC resolution rate was 
significantly better in patients given rTM (83.3% vs. 52.8%, p  0.01), but that there was 
no significant difference in mortality (13.3% vs. 27.8%, p = 0.26) (CS) [23]. In a study by 
Nakahara et al. of 13 patients with acute cholangitis-induced DIC, seven patients who 
were treated with rTM had significantly lower DIC scores compared with six who were 
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only treated with antithrombin III (CS) [24]. Both those studies were case series with 
insufficient numbers of patients to provide more than a low level of evidence, but as there 
were no serious side effects, the use of rTM in patients with severe cholangitis 
complicated by DIC may be considered. 
 
Flowchart for the management of acute cholangitis and cholecystitis 
After severity has been assessed and the patient’s general status has been evaluated, a 
treatment strategy should be decided on the basis of the flowchart for the management of 
acute cholangitis or acute cholecystitis, and treatment should immediately be provided. 
With the exception of part of the management of moderate cholangitis, the TG18 
flowchart for the management of acute cholangitis is little changed from TG13 (CPG) 
[12]. Acute cholangitis should be managed in accordance with its severity. Biliary 
drainage and antibiotics are the two key pillars of the treatment of acute cholangitis. In 
some cases of acute cholangitis, acute cholecystitis may also be present; in this event the 
treatment strategy should be decided in consideration of the severity of both and the 
patient’s general status (CPG) [12]. If blood culture has not been performed as part of the 
initial response, it should be carried out before antibiotic administration. If biliary 
drainage is performed, bile samples must always be sent for culture. 
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For the flowchart for the management of acute cholecystitis, see TG18: Flowchart for 
the management of acute cholecystitis (CPG) [3]. 
 
Flowchart for the management of acute cholangitis (Figure 2) 
Grade I (mild acute cholangitis) 
Mild acute cholangitis is defined as cholangitis that does not meet the TG18 severity 
assessment criteria for moderate or severe cholangitis below (CPG) [9]. In most cases 
initial treatment including antibiotics is sufficient, and most patients do not require 
biliary drainage. However, biliary drainage should be considered if a patient does not 
respond to initial treatment. EST and subsequent choledocholithotomy may be performed 
at the same time as biliary drainage. Postoperative cholangitis usually improves with 
antibiotic treatment alone, and biliary drainage is not usually required (CPG)[12]. 
 
Grade II (moderate acute cholangitis) 
Moderate acute cholangitis is cholangitis that is not severe but requires early biliary 
drainage. In the TG18 severity assessment criteria, moderate cholangitis is assessed if at 
least two of the following five criteria are met: WBC 12,000 or 4000, temperature 39 
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ºC, age 75 years, total bilirubin 5 mg/dL, or albumin (lower limit of normal value  
0.73 g/dL) (CPG)[9].  
Early endoscopic or percutaneous transhepatic biliary drainage is indicated. If the 
underlying etiology requires treatment, this should be provided after the patient’s 
general condition has improved (CPG)[12], and EST and subsequent choledocholithotomy 
may be performed together with biliary drainage. 
Grade III (severe acute cholangitis) 
Severe acute cholangitis is cholangitis with sepsis-induced organ damage. In the TG18 
severity assessment criteria, severe cholangitis is assessed if any one of the following 
criteria is met: cardiovascular dysfunction (requiring the use of dopamine  5 g/kg/min 
or noradrenaline), neurological dysfunction (disturbance of consciousness), respiratory 
dysfunction (PaO2/FiO2 ratio 300), renal dysfunction (oliguria or serum creatinine >2.0 
mg/d), hepatic dysfunction (PT-INR 1.5), or coagulation disorder (platelet count 104/L) 
(CPG)[9].  
As the patient’s condition may deteriorate rapidly, a swift response is essential 
including appropriate respiratory/circulatory management (tracheal intubation followed 
by artificial ventilation and the use of hypertensive agents). Endoscopic or percutaneous 
transhepatic biliary drainage should be performed as soon as possible after the patient’s 
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condition has been improved by initial treatment and respiratory/circulatory 
management. If treatment for the underlying etiology is required, this should be provided 
after the patient’s general status has improved (CPG)[12]. 
 
Transfer criteria 
 Table 5 shows the transfer criteria for acute cholangitis. If a hospital is not equipped to 
perform endoscopic or percutaneous transhepatic biliary drainage or provide intensive 
care, patients with moderate or severe cholangitis should preferably be transferred to a 
hospital capable of providing these treatments, irrespective of whether or not they are 
actually required (CPG)[25]. 
 
Acknowledgments 
We express our deep gratitude to the Japanese Society of Hepato-Biliary-Pancreatic 
Surgery, the Japanese Society of Abdominal Emergency Medicine, the Japanese Society 
of Surgical Infection, and the Japan Biliary Association, for their substantial support and 
guidance in the preparation of this article. We also would like to express our deep 
gratitude to the Japanese Society of Hepato-Biliary-Pancreatic Surgery for the Article 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Processing Managing Office of the Tokyo Guidelines 18 for preparing this publication. We 
appreciate all secretariats of the Japanese Society of Hepato-Bilialy-Pancreatic Surgery 
for their technical support. 
 
Conflict of interest 
Goro Honda has received honoraria from Johnson and Johnson and Medtronics. 
 
References 
1.  Miura F, Takada T, Kawarada Y, Nimura Y, Wada K, Hirota M, et al. Flowcharts 
for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo 
Guidelines. J Hepatobiliary Pancreat Surg. 2007;14:27-34 (レベル A) 
2.  Takada T, Strasberg SM, Solomkin JS, Pitt HA, Gomi H, Yoshida M, et al. TG13: 
Updated Tokyo Guidelines for the management of acute cholangitis and 
cholecystitis. Journal of hepato-biliary-pancreatic sciences. 2013;20:1-7 
3.  Okamoto K. TG18: Flowchart for the management of acute cholecystitis. Journal 
of hepato-biliary-pancreatic sciences. 2018 
4.  Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA, et al. New 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo 
Guidelines. Journal of hepato-biliary-pancreatic sciences. 2012;19:548-56 
5.  Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA, et al. 
TG13 guidelines for diagnosis and severity grading of acute cholangitis (with 
videos). Journal of hepato-biliary-pancreatic sciences. 2013;20:24-34 
6.  Kiriyama S. Diagnostic and severity grading criteria for acute cholangitis in 
TG18. Journal of hepato-biliary-pancreatic sciences. 2018 
7.  Yokoe M, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Gomi H, et al. New 
diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo 
Guidelines. Journal of hepato-biliary-pancreatic sciences. 2012;19:578-85 
8.  Yokoe M, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Gomi H, et al. TG13 
diagnostic criteria and severity grading of acute cholecystitis (with videos). 
Journal of hepato-biliary-pancreatic sciences. 2013;20:35-46 
9.  Yokoe H. TG18 Diagnostic criteria and severity grading of acute cholecystitis. 
Journal of hepato-biliary-pancreatic sciences. 2018 
10.  Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying 
prognostic comorbidity in longitudinal studies: development and validation. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Journal of chronic diseases. 1987;40:373-83 
11.  ASA Physical Status Classification System Last approved by the ASA House of 
Delegates on October 15, 2014. 
https://www.asahq.org/resources/clinical-information/asa-physical-status-classific
ation-system. 
12.  Miura F, Takada T, Strasberg SM, Solomkin JS, Pitt HA, Gouma DJ, et al. TG13 
flowchart for the management of acute cholangitis and cholecystitis. Journal of 
hepato-biliary-pancreatic sciences. 2013 
13.  Thomas SH, Silen W, Cheema F, Reisner A, Aman S, Goldstein JN, et al. Effects of 
morphine analgesia on diagnostic accuracy in Emergency Department patients 
with abdominal pain: a prospective, randomized trial. J Am Coll Surg. 
2003;196:18-31 
14.  Gallagher EJ, Esses D, Lee C, Lahn M, Bijur PE. Randomized clinical trial of 
morphine in acute abdominal pain. Ann Emerg Med. 2006;48:150-60, 60 e1-4 
15.  Gomi H. TG18: Antimicrobial therapy for acute cholangitis and cholecystitis. 
Journal of hepato-biliary-pancreatic sciences. 2018 
16.  Kiriyama S, Takada T, Miura F, Gomi H, Itoi T, Yokoe M. Clinical application and 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
verification of TG 13 diagnostic criteria and severity assessment among patients 
with acute cholangitis: An international multi center observational study. Journal 
of hepato-biliary-pancreatic sciences. 2017 
17.  Jang SE, Park SW, Lee BS, Shin CM, Lee SH, Kim JW, et al. Management for 
CBD stone-related mild to moderate acute cholangitis: urgent versus elective 
ERCP. Digestive diseases and sciences. 2013;58:2082-7 
18.  Eto K, Kawakami H, Haba S, Yamato H, Okuda T, Yane K, et al. Single-stage 
endoscopic treatment for mild to moderate acute cholangitis associated with 
choledocholithiasis: a multicenter, non-randomized, open-label and exploratory 
clinical trial. Journal of hepato-biliary-pancreatic sciences. 2015;22:825-30 
19.  Ito T, Sai JK, Okubo H, Saito H, Ishii S, Kanazawa R, et al. Safety of immediate 
endoscopic sphincterotomy in acute suppurative cholangitis caused by 
choledocholithiasis. World journal of gastrointestinal endoscopy. 2016;8:180-5 
20.  Lee JC, Moon JH, Choi HJ, Kim DC, Choi MH, Lee TH, et al. Delayed endoscopic 
papillary large balloon dilation after sphincterotomy for removing large bile duct 
stones in patients with acute cholangitis. Digestive diseases and sciences. 
2014;59:1302-6 
21.  Zhu B, Wang Y, Gong K, Lu Y, Ren Y, Hou X, et al. Comparison of emergent versus 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
elective laparoscopic common bile duct exploration for patients with or without 
nonsevere acute cholangitis complicated with common bile duct stones. The 
Journal of surgical research. 2014;187:72-6 
22.  Zhu B, Li D, Ren Y, Li Y, Wang Y, Li K, et al. Early versus delayed laparoscopic 
common bile duct exploration for common bile duct stone-related nonsevere acute 
cholangitis. Sci Rep. 2015;5:6 
23.  Suetani K, Okuse C, Nakahara K, Michikawa Y, Noguchi Y, Suzuki M, et al. 
Thrombomodulin in the management of acute cholangitis-induced disseminated 
intravascular coagulation. World journal of gastroenterology. 2015;21:533-40 
24.  Nakahara K, Okuse C, Adachi S, Suetani K, Kitagawa S, Okano M, et al. Use of 
antithrombin and thrombomodulin in the management of disseminated 
intravascular coagulation in patients with acute cholangitis. Gut and liver. 
2013;7:363-70 
25.  The revision committee for the guidelines of acute cholangitis and cholecystitis. 
Guidelines of acute cholangitis and cholecystitis 2013  Tokyo: 
Igakutosho-shuppan Ltd.; 2013 in Japanese. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
Results of Public Hearing 
At the TG18 public hearing held on June 9, 2017, participants were asked to give their 
opinions on two questions about the flowchart for acute cholangitis on an answer pad.   
To the first question, “Do you agree to perform treatment for etiology simultaneously, if 
possible, with biliary drainage for moderate cholangitis?” 90% of participants chose either 
“Strongly agree” or “Agree” as their response (Figure 3). To the second question, “Do you 
agree to revise flowchart for the management of acute cholangitis?” 90% also chose either 
“Strongly agree” or “Agree” as their response (Figure 4). This was considered to indicate the 
validity of the changes to the current flowchart. 
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Figure legend 
 
Figure 1 TG18 Flowchart for the Initial Response to Acute Biliary Infection 
 
Figure 2 TG18 Flowchart for the Management of Acute Cholangitis 
 
Figure 3 Answers to the question "Do you agree to perform treatment for etiology 
simultaneously, if possible with biliary drainage for moderate cholangitis?". No [Strongly 
disagree] answers from the panelists. 
 
Figure 4 Answers to the question "Do you agree to revise flowchart for the management 
of acute cholangitis?" No [Strongly disagree] answers from the panelists. 
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